We demonstrate that changes in the expression intensity and location of HMGB1 are particularly relevant in pre-malignant oesophageal pathology and progression towards malignancy, rather than offering a discriminatory biomarker in cancer itself. The gene discussed is HMGB1; the disease is cancer.